Recent Quotes (30 days)

You have no recent quotes
chg | %

TSO3 Inc.  

(Public, TSE:TOS)   Watch this stock  
Find more results for TOS
2.57
-0.02 (-0.77%)
Aug 22 - Close
TSE data delayed by 15 mins - Disclaimer
Currency in CAD
Range 2.51 - 2.62
52 week 2.20 - 3.69
Open 2.59
Vol / Avg. 465,103.00/140,414.00
Mkt cap 237.84M
P/E     -
Div/yield     -
EPS -0.11
Shares 92.74M
Beta 1.59
Inst. own     -
Nov 6, 2017
Q3 2017 TSO3 Inc Earnings Release (Estimated) Add to calendar
Aug 10, 2017
TSO3 Inc at Canaccord Genuity Growth Conference
Aug 2, 2017
Q2 2017 TSO3 Inc Earnings Call
Aug 1, 2017
Q2 2017 TSO3 Inc Earnings Release
  

Key stats and ratios

Q2 (Jun '17) 2016
Net profit margin -48.68% -32.92%
Operating margin -47.34% -31.72%
EBITD margin - -41.20%
Return on average assets -35.08% -18.81%
Return on average equity -57.57% -31.50%
Employees 49 -
CDP Score - -

Address

2505 Dalton Ave
QUEBEC, QC G1P 3S5
Canada
+1-418-6510003 (Phone)
+1-418-6535726 (Fax)

Website links

Description

TSO3 Inc is a Canada-based company engaged in the sale, production, maintenance, research, development and licensing of sterilization processes, related consumable supplies and accessories for heat-sensitive medical devices. The Company designs products for sterile processing areas in the hospital environment. The Company's products are used in the sterilization departments of hospital and other medical facilities. It also provides services related to the maintenance of sterilization equipment and compatibility testing of medical devices with such processes. It has developed a sterilizer using a sterilization process based on ozone as the sterilizing agent. The Company's STERIZONE VP4 Sterilizer is a dual sterilant, low temperature sterilization system that utilizes vaporized hydrogen peroxide (H2O2) and ozone (O3) as its sterilants. The STERIZONE VP4 terminally sterilizes multiple channels in a single device.

Officers and directors

Germain Carriere Independent Chairman of the Board
Richard M. Rumble President, Chief Executive Officer, Director
Glen Kayll Chief Financial Officer
Age: 46
Mark E Pasmore Ph.D. Vice President - Research and Development
Simon Robitaille Corporate Secretary Secretary
Steven M. West Director
Age: 61
Pierre Desy Independent Director
Jean Lamarre Independent Director
Age: 63
Claude Michaud Independent Director
Jeffrey Pompeo Independent Director